The results were driven by a 12% increase on a like-for-like basis at constant exchange rates, fueled primarily by sustained demand for night vision and digital imaging solutions within defense applications.

Revenue in the Amplification segment rose 11.4% to EUR 88.1 million, while the Detection & Imaging segment surged 44.5% to EUR 34.6 million, including 16.6% organic growth.

Exosens also reported a 20.1% increase in adjusted gross profit to EUR 63.5 million, representing a 51.8% margin. Both segments saw double-digit growth in this metric, with Amplification up 15% and Detection & Imaging up 36.8%.

'Against a backdrop of heightened geopolitical tensions, demand for critical digital imaging and night vision solutions continues to accelerate, positioning Exosens to capture significant growth opportunities,' stated CEO Jérôme Cerisier.

Furthermore, the group confirmed it remains fully on track to meet its 2026 targets, which include revenue between EUR 520 million and EUR 540 million and adjusted EBITDA between EUR 168 million and EUR 178 million. Capital expenditures are projected at approximately 9% of revenue, excluding capitalized R&D costs.